News Escalier raises $19m to fund novel psoriasis pill Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.
Views & Analysis A new fast track for NHS access - good news for niche innova... The UK is about to launch The Accelerated Access Collaborative: a new initiative aimed at speeding potential breakthroughs to market.
Views & Analysis Healthcare in 2030: what role for pharma? Prevention and self-management increasingly important in healthcare systems of the future.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
